Pituitary adenylate cyclase-activating polypeptides ( PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP

This publication has 35 references indexed in Scilit:

• The influence of neuroendocrine pathways on lymphocyte migration
  Immunology Today, 1994
• The syntax of immune-neuroendocrine communication
  Immunology Today, 1994
• Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex
  Journal of Neuroimmunology, 1994
• Gene Expression of VIP Receptor in Rat Lymphocytes
  Biochemical and Biophysical Research Communications, 1994
• Type I receptors for PACAP (a neuropeptide even more important than VIP?)
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
• Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes
  Journal of Neuroimmunology, 1993
• Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes
  European Journal of Pharmacology: Molecular Pharmacology, 1991
• N -Formyl-methionyl-leucyl-phenylalanine induced accumulation of inositol phosphates indicates the presence of oligopeptide chemoattractant receptors on circulating human lymphocytes
  FEBS Letters, 1989
• Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
  Biochemical and Biophysical Research Communications, 1989
• Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: Specific binding and cyclic AMP production
  General Pharmacology: The Vascular System, 1986